Advertisement

International Journal of Public Health

, Volume 58, Issue 2, pp 319–322 | Cite as

Community-based pharmacies: an opportunity to recruit patients?

  • Isabelle Peytremann-BridevauxEmail author
  • Julie Bordet
  • Valérie Santschi
  • Tinh-Hai Collet
  • Marc Eggli
  • Bernard Burnand
Hints & Kinks

Introduction

Recruiting representative population groups with a specific disease is a challenge. In jurisdictions with no existing or no access to a database including individual disease diagnoses (e.g., electronic medical records), there are few satisfying strategies. Usually, population health surveys do not provide enough diagnostic information and may not allow recruiting large enough samples to study a specific disease. Registries or clinical cohorts may exist for specific diseases, but are often not truly population-based. Recruitment from patients’ associations and physicians’ practices may also be selective. In addition, the latter is difficult to run in busy primary care clinics. Finally, the type of information and the possibility to access health insurances’ databases may preclude their use. For diseases that require treatment involving pharmacies regularly, we propose to recruit patients in community pharmacies; this has been seldom described (Knoester et al. 2005; Van...

Keywords

Patients recruitment Diabetes Pharmacies roles 

Notes

Acknowledgments

We would like to thank all pharmacies, diabetic patients and practicing physicians who participated in the study. We also thank the partners and members of the working group for their collaboration. We thank Mrs. Lucienne Boujon for copy editing the manuscript. This study was funded by the Department of Public Health of the canton of Vaud. Dr. I. Peytremann-Bridevaux is supported by a grant from the Swiss National Science Foundation [PROSPER N° 32333B-123817 and N° 32333B-139789].

Conflict of interest

None of the authors has conflict of interest to declare.

References

  1. Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I (2011) Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton. Diabetes Metab Syndr Obes 4:213–223PubMedCrossRefGoogle Scholar
  2. Hagon-Traub I, Hirsiger P, Bovet P, Ruiz J, Peytremann-Bridevaux I, Noth C, Hauschild (2010) Programme cantonal Diabète, présentation du programme. Lausanne: Service de la Santé Publique du canton de Vaud. http://www.vd.ch/fileadmin/user_upload/themes/sante_social/services_soins/Diabete/fichiers_pdf/Programme_cantonal.pdf
  3. Hersberger KE, Botomino A, Mancini M, Bruppacher R (2006) Sequential screening for diabetes—evaluation of a campaign in Swiss community pharmacies. Pharm World Sci 28:171–179PubMedCrossRefGoogle Scholar
  4. Knoester PD, Belister SV, Deckers CLP, Keyser A, Renier WO, Egberts ACG, Hekster YA (2005) Recruitment of a cohort of lamotrigine users through community pharmacists: differences between patients who gave informed consent and those who did not. Pharmacoepidemiol Drug Saf 14:107–112PubMedCrossRefGoogle Scholar
  5. McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT, SCRIP-HTN Investigators et al (2008) A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med 168:2355–2361PubMedCrossRefGoogle Scholar
  6. Nolte E, Knai C, McKee M (2008) Managing chronic conditions: experience in eight countries. World Health Organization on behalf of the European Observatory on Health Systems and Policies, CopenhagenGoogle Scholar
  7. Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G (2011) Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med 171:1441–1453PubMedCrossRefGoogle Scholar
  8. Van Wieren-de Wijer DB, Maitland-van der Zee AH, de Boer A, Stricker BH, Kroon AA, de Leeuw PW, Bozkurt O, Klungel OH et al (2009) Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment. Pharm World Sci 31:158–164PubMedCrossRefGoogle Scholar

Copyright information

© Swiss School of Public Health 2012

Authors and Affiliations

  • Isabelle Peytremann-Bridevaux
    • 1
    Email author
  • Julie Bordet
    • 1
  • Valérie Santschi
    • 1
  • Tinh-Hai Collet
    • 2
  • Marc Eggli
    • 3
  • Bernard Burnand
    • 1
  1. 1.Institute of Social and Preventive Medicine (IUMSP)Lausanne University HospitalLausanneSwitzerland
  2. 2.Department of Ambulatory Care and Community MedicineUniversity of LausanneLausanneSwitzerland
  3. 3.Service of Endocrinology, Diabetes, and MetabolismLausanne University HospitalLausanneSwitzerland

Personalised recommendations